Secant Medical Relocates Corporate Headquarters To Telford, Pennsylvania
06/29/2015
According to company officials, the firm has been investing heavily in the regenerative medicine field through the enhancement of its operations and new biomaterials platform technology development.
“The Telford facility is geared toward innovation and it will further position Secant Medical to accommodate future growth,” said Jeff Robertson, President of Secant Medical. “This is an exciting time for our company and we look forward to providing our customers with more value-added services and growing stronger partnerships.”
The existing Perkasie and Quakertown facilities have served as the development, manufacturing and corporate headquarters for the past 70 years, but have reached expansion limits and can no longer support the company’s growth demands, officials said. Moving the headquarters to Telford was the first stage in Secant Medical’s facilities relocations, a company spokesperson said.
The company is keeping the Quakertown facility and a second move will take place in the fall of 2015 after the space has been retrofitted to provide suitable building designs for customer requirements, allow for additional space to perform operations, and assure orderly handling of customer product. One building in Perkasie will remain as a manufacturing site.
Project Announcements
Fukoku Korea Plans Henry County, Virginia, Manufacturing Operations
03/13/2026
Germany-Based Sennheiser Group Plans Nashville, Tennessee, Operations
03/12/2026
Interstate Group Expands Giles County, Virginia, Production Operations
03/11/2026
Shinhwa Auto USA Expands Auburn, Alabama, Operations
03/11/2026
General Atomics Expands Shannon, Mississippi, Production Operations
03/11/2026
Starbucks Plans Davidson County, Tennessee, Corporate Operations
03/08/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025